Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > TBP SIGNS LICENSE AGRMNT WITH THORNE HEALTH/PREBIOTIC SUPLMN

<< Previous

Bullboard Posts

Next >>

Comment by Golddetectoron Feb 22, 2022 10:35am

110 Views

Post# 34450060

RE:RE:RE:RE:TBP SIGNS LICENSE AGRMNT WITH THORNE HEALTH/PREBIOTIC SUPLMN

These reoccurring income is great sources of revenue. I'm more food suppliers will be using the patent. More money coming in. Well we thought Tbp 1st revenue will come from sales it really coming from patent.

<< Previous

Bullboard Posts

Next >>

Anaergia expands relationship with PepsiCo